Ph.D. in Molecular Oncology is a specialized research program that aims to better understand the molecular pathways that drive cancer genesis, progression, and treatment. The curriculum, which typically lasts 3-5 years, includes molecular biology, genetics, biochemistry, and oncology, with a particular emphasis on tumor biology, cancer genomics, signaling pathways, and therapeutic targets. Students do unique research to investigate genetic and epigenetic changes in cancer cells, cancer immunotherapy, targeted medication development, and the tumor microenvironment. Graduates frequently pursue positions in academia, the pharmaceutical and biotechnology businesses, medical research institutes, and oncology clinical trials. Admission normally requires a Master's degree in molecular biology, biochemistry, or a similar discipline, as well as a solid understanding of cancer biology and research methods.
